Internal Medicine, Hematology & Oncology · Fayetteville, GA
NPI
1457545709
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1267 Highway 54 W Ste 4200
Fayetteville, GA, 30214
Phone (678) 829-1060
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.1M
254,069 services
Medicare patients, 2024
760
Average age 75
Drug cost, 2024
$8.6M
4,310 prescriptions
Company payments, 2025
$95K
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Trevor Feinstein was code J1442 (injection, filgrastim (g-csf), excludes biosimilars, 1 microgram), 37,560 times for 16 patients. In total Trevor Feinstein billed 254,069 services in 140 codes, and Medicare paid $4.1M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-07-02.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1442 Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram | Office | 37,560 | 16 | $0.73 | $27K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 21,200 | 22 | $42.45 | $900K |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 12,600 | 11 | $0.05 | $658 |
| J0897 Injection, denosumab, 1 mg | Office | 11,820 | 65 | $19.27 | $228K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 5,400 | 46 | $14.72 | $79K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,524 | 55 | $0.08 | $212 |
| 85025 Blood Count | Office | 1,395 | 622 | $7.51 | $10K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,100 | 23 | $0.69 | $758 |
| J0640 Injection, leucovorin calcium, per 50 mg | Office | 630 | 13 | $3.27 | $2,057 |
| 96413 Chemotherapy Administration | Office | 599 | 114 | $91.16 | $55K |
| J9196 Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg | Office | 550 | 13 | $5.63 | $3,095 |
| J9190 Injection, fluorouracil, 500 mg | Office | 534 | 16 | $2.11 | $1,126 |
| 99214 Office E&M - Established | Office | 516 | 261 | $88.28 | $46K |
| 99213 Office E&M - Established | Office | 504 | 375 | $57.63 | $29K |
| 96372 Injection Administration | Office | 447 | 139 | $10.08 | $4,508 |
By year: 2022 $4.3M for 235,240 services; 2023 $4.0M for 290,394 services; 2024 $4.1M for 254,069 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,395 | 622 | $7.51 | $10K |
| 81002 Clinical Chemistry | 46 | 35 | $3.26 | $150 |
Medicare prescription drug claims, 2024
In 2024, the drug Trevor Feinstein prescribed most often to Medicare patients was Anastrozole, with 410 prescriptions and refills. In total Trevor Feinstein wrote 4,310 Medicare prescriptions that cost $8.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 410 | 1,090 | 113 | $7,704 |
| Eliquis Apixaban | 188 | 288 | 52 | $165K |
| Ondansetron Odt Ondansetron | 159 | 161 | 111 | $2,615 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 153 | 153 | 38 | $3,675 |
| Prochlorperazine Maleate Generic | 114 | 116 | 88 | $1,778 |
| Valacyclovir Valacyclovir Hcl | 112 | 167 | 23 | $3,549 |
| Letrozole Generic | 106 | 273 | 32 | $2,134 |
| Potassium Chloride Generic | 99 | 111 | 44 | $1,269 |
| Dexamethasone Generic | 97 | 101 | 60 | $2,401 |
| Xarelto Rivaroxaban | 93 | 151 | 21 | $84K |
| Tramadol Hcl Generic | 92 | 92 | 31 | $525 |
| Prednisone Generic | 92 | 100 | 38 | $415 |
| Hydroxyurea Generic | 90 | 165 | 20 | $1,860 |
| Gabapentin Generic | 88 | 143 | 29 | $1,303 |
| Alendronate Sodium Generic | 86 | 215 | 33 | $602 |
Brand drugs: - claims; generic drugs: 3,359 claims; opioid claims: 419.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Trevor Feinstein $95K ($95K in general payments such as food, travel and fees) from 27 companies. The largest payer was Genzyme Corporation with $43K.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 28 | $43K |
| AstraZeneca Pharmaceuticals LP AZN | 29 | $36K |
| Recordati_rare_diseases_inc. | 7 | $9,021 |
| Daiichi Sankyo Inc. 4568.T | 9 | $5,979 |
| Gilead Sciences, Inc. GILD | 2 | $255 |
| Merck Sharp & Dohme LLC MRK | 6 | $228 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $214 |
| Abbvie Inc. ABBV | 8 | $176 |
| Amgen Inc. AMGN | 2 | $39.21 |
| GlaxoSmithKline, LLC. GSK | 1 | $28.08 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.